Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 53:34 In the Pipeline: Dystrophin Restoration 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 54:53 In the Pipeline: Protecting the Muscle (PPMD’s 2021 Virtual Annual Conference) 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 49:53 In the Pipeline: Gene Editing 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 58:55 In the Pipeline: Gene Therapy 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 51:09 In the Pipeline: Reducing Inflammation 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 55:32 In the Pipeline: Improving the Heart and Mitochondria 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 1:10:27 In the Pipeline: Pre-Clinical Gene Therapy 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 47:59 In the Pipeline: Next-Gen Exon Skipping 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings «1…1112131415…25»Page 13 of 25
by: Parent Project Muscular Dystrophy
